Allianz's Robotaxi Bet Meets Its Buyback Test: Two Clocks Ticking Toward November 12

Allianz will insure Waymo's robotaxis for Europe's rollout from Munich, while continuing share repurchases ahead of Q3 results on November 12.

Allianz has spent the past week doing two things at once: buying back its own stock and staking out territory in a business that barely exists yet. The Munich-based insurer confirmed a multi-year partnership with Waymo, Alphabet's robotaxi unit, while simultaneously disclosing a fresh batch of share repurchases — twin signals that management intends to fund both the present and the future without choosing between them.

Under the deal, first reported by Handelsblatt and initially set to run three years, Allianz Partners will provide fleet and liability coverage for Waymo's autonomous vehicles when the company enters Europe, alongside claims handling through the Solvd Group and crash research via the Allianz Center for Technology. Germany is the launchpad: Waymo announced a German market entry at the end of August, with test drives slated for Munich this autumn and commercial operations targeted for late 2027. London is the next city under discussion.

A Stock Already Priced for Good News

The timing is hardly accidental. Allianz shares sit just 1.2% below their 52-week high after a 1.3% gain in today's session — the fourth consecutive winning day. The stock has added 2.9% over the week and 15% since the start of the year, a run that leaves it looking stretched on momentum indicators. The relative strength index is flashing overbought, and analyst price targets have drifted far apart, a divergence market watchers read as a sign of valuation uncertainty.

That backdrop cuts both ways. Bulls see a company positioning itself early in a segment previously dominated by technology firms. Bears see a stock that has run too far, too fast, on a deal whose revenue contribution is not yet quantified.

The Real Question Is Premium Volume, Not Prestige

Waymo says it already operates more than 500,000 driverless trips per week in the United States — a volume that hints at how much fleet and liability insurance could eventually migrate to Europe. But the European rollout is in its infancy, and no meaningful premium income will flow before commercial operations begin at the end of 2027. What matters for investors, then, is not the announcement effect but the pace at which Waymo actually puts fleets on the road — and how much of that converts into premiums for Allianz Partners once testing gives way to regular service.

The partnership's four pillars — insurance, claims adjustment, safety research and vehicle recovery — form an integrated ecosystem that could be extended to other operators and markets if Waymo expands beyond Germany. For a stock already buoyed by strong half-year results, a credible foothold in future mobility would be an additional growth layer alongside the established core business.

Regulatory risk is the obvious counterweight. Europe's rules for autonomous driving may prove considerably stricter than America's, and any delay in the rollout would push the growth story further out than the market has priced in.

The Buyback Engine and Its Fuel Gauge

While the robotaxi narrative grabs headlines, Allianz's quieter story is its capital return machine. Between September 7 and 11, the group repurchased another 303,283 of its own shares. Since the current program began on March 13, the tally has reached just under 5.94 million shares, bought at average prices between EUR 436.50 and EUR 447.28. The buyback runs in parallel with the already-consumed takeover saga surrounding AA, the British roadside assistance provider.

At EUR 447.40, the stock trades just 1.6% below its 52-week high of EUR 454.50, set on September 3 — evidence that the market still believes Allianz can absorb both buybacks and acquisitions without eroding its capital base. The metric that governs that belief is the Solvency II ratio, the true throttle on how much room the group has for repurchases, dividends and deals before regulators demand it hoard capital. So long as the ratio stays comfortably above supervisory comfort levels, the two ambitions need not cannibalize each other.

The arithmetic gets tighter if the AA offer, reportedly under discussion, swells from the originally planned EUR 5.8 billion to roughly USD 6.77 billion. That would tie up part of the buffer and sharpen questions about capital allocation. Of the up to EUR 2.5 billion earmarked for the buyback program launched in February, EUR 1.4 billion was already spent in the first half — a clear signal that management is not sidelining shareholder returns to chase the acquisition.

Boardroom Rewiring Adds a Third Variable

Allianz also faces a leadership transition. Günther Thallinger will leave the management board at the end of 2026, and the board will shrink from nine members to eight. Tomas Kunzmann is slated to step up on January 1, 2027, taking over the Asia-Pacific region and global health insurance portfolio currently overseen by Klaus-Peter Röhler. The reshuffle must proceed without operational friction, or it will consume bandwidth at an already busy moment.

Sentiment on the stock is not uniformly bullish. Barclays has kept its "Underweight" rating, a stance that implies a notable gap to the current share price and points to lingering structural valuation doubts.

Two Clocks, One Date

Near term, the technical picture matters. As long as the shares hold above their 50-day moving average of EUR 436.37, the uptrend remains intact, though a breather would not surprise anyone given the overbought reading. A decisive break below that line would lend weight to the consolidation scenario some observers expect — and could hand new investors a more attractive entry point.

Medium term, the proof will come from Munich. First test drives this autumn and their results should indicate whether the timeline to a commercial launch in late 2027 holds. On the capital side, the question is whether operating earnings — Allianz still targets EUR 17.4 billion in operating profit for the year, give or take EUR 1 billion — generate enough free capital surplus to digest a pricier AA deal without tapping the brakes on buybacks.

Both threads converge on November 12, when Allianz reports third-quarter figures. That is when the market will learn whether operational momentum and capital cushion are moving in step through a year of restructuring and acquisition — and whether the robotaxi story is more than a placeholder on a slide.